Anti-LRP5/6 antibodies and methods of use
US11746150B2 · kind B2 · utility
1Cited by
29References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2018 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | May 15, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/32
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides anti-LRP5/6 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for treating diseases and disorders associated with Wnt pathway signaling.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.